Press Release | NeoGenomics Laboratories

April 3, 2019

NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019

April 2, 2019

NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference

March 11, 2019

NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)

March 7, 2019

NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

February 19, 2019

NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

January 28, 2019

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

December 13, 2018

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

December 12, 2018

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients